西点药业(301130.SZ)：横琴鼎典及其一致行动人累计减持1.0001%股份

Core Viewpoint - West Point Pharmaceutical (301130.SZ) announced a share reduction plan involving the sale of 765,019 shares, representing 1.0001% of the company's total equity, by Hengqin Dingdian and its concerted action party, Zhuhai Hengqin Runhuiyi, through centralized bidding or block trading from October 27, 2025, to November 3, 2025 [1] Summary by Category - Share Reduction Details - The share reduction involves a total of 765,019 shares [1] - This amount constitutes 1.0001% of the company's total share capital [1] - The reduction plan is not yet fully executed [1]